93 related articles for article (PubMed ID: 8079383)
1. Chromatographic resolution of the type II estrogen binding site and a tyrosinase-like enzymatic activity from rat uterine nuclei.
Densmore CL; Schauweker TH; Gregory RR; Webb B; Garcia E; Markaverich BM
Steroids; 1994 Apr; 59(4):282-7. PubMed ID: 8079383
[TBL] [Abstract][Full Text] [Related]
2. Tyrosinase-like activity and estradiol binding in rat uterine nuclear extracts.
Garai J; Clark JH
Steroids; 1992 May; 57(5):248-56. PubMed ID: 1488787
[TBL] [Abstract][Full Text] [Related]
3. Estrogen affinity crosslinking to tyrosinase-like immunoreactive proteins of rat uterine nuclear extracts.
Garai J; Clark JH
J Steroid Biochem Mol Biol; 1994 Jun; 49(2-3):161-5. PubMed ID: 8031712
[TBL] [Abstract][Full Text] [Related]
4. Nuclear binding of the estrogen receptor: heterogeneity of sites and uterotropic response.
Clark JH; Markaverich B; Upchurch S; Eriksson H; Hardin JW
Adv Exp Med Biol; 1979; 117():17-46. PubMed ID: 474276
[TBL] [Abstract][Full Text] [Related]
5. An improved method for the quantification and recovery of rat uterine nuclear type II [3H]estradiol binding sites immobilized on a glass fiber matrix.
Densmore CL; Tiller AA; Gregory RR; Schauweker TH; Webb B; Markaverich BM
Steroids; 1995 Feb; 60(2):214-9. PubMed ID: 7618188
[TBL] [Abstract][Full Text] [Related]
6. Purification and characterization of nuclear type II [(3)H]estradiol binding sites from the rat uterus: covalent labeling with [(3)H]luteolin.
Markaverich BM; Shoulars K; Brown MA
Steroids; 2001 Sep; 66(9):707-19. PubMed ID: 11546559
[TBL] [Abstract][Full Text] [Related]
7. Preliminary assessment of luteolin as an affinity ligand for type II estrogen--binding sites in rat uterine nuclear extracts.
Markaverich BM; Gregory RR
Steroids; 1993 Jun; 58(6):268-74. PubMed ID: 8212072
[TBL] [Abstract][Full Text] [Related]
8. Eosinophils as the source of uterine nuclear type II estrogen binding sites.
Lyttle CR; Medlock KL; Sheehan DM
J Biol Chem; 1984 Mar; 259(5):2697-700. PubMed ID: 6698988
[TBL] [Abstract][Full Text] [Related]
9. Tyrosinase-like polypeptides in the uterus and in the central nervous system of rats.
Garai J; Tiller AA; Clark JH
Steroids; 1992 Apr; 57(4):183-8. PubMed ID: 1519262
[TBL] [Abstract][Full Text] [Related]
10. The effect of low dose continuous exposure to estradiol on the estrogen receptor (type I) and nuclear type II sites.
Markaverich BM; Roberts RR; Alejandro M; Clark JH
Endocrinology; 1984 Mar; 114(3):814-20. PubMed ID: 6697964
[TBL] [Abstract][Full Text] [Related]
11. Estradiol-stimulated increases in uterine eosinophils and nuclear type II estrogen-binding sites are prevented by pertussis toxin.
Lyttle CR; Teuscher C; Medlock KL; Sheehan DM
Endocrinology; 1989 Nov; 125(5):2773-9. PubMed ID: 2792007
[TBL] [Abstract][Full Text] [Related]
12. Preliminary characterization and partial purification of rat uterine nuclear type II Binding sites.
Markaverich BM; Gregory RR
Biochem Biophys Res Commun; 1991 Jun; 177(3):1283-90. PubMed ID: 2059216
[TBL] [Abstract][Full Text] [Related]
13. Role of estrogen receptor binding and transcriptional activity in the stimulation of hyperestrogenism and nuclear bodies.
Clark JH; Hardin JW; Padykula HA; Cardasis CA
Proc Natl Acad Sci U S A; 1978 Jun; 75(6):2781-4. PubMed ID: 275847
[TBL] [Abstract][Full Text] [Related]
14. An endogenous ligand for type II binding sites in normal and neoplastic tissues.
Clark JH; Markaverich BM
Adv Exp Med Biol; 1986; 196():305-15. PubMed ID: 3716924
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of nuclear estrogen-binding sites in the rat uterus: a simple method for the quantitation of type I and type II sites by [3H]estradiol exchange.
Markaverich BM; Williams M; Upchurch S; Clark JH
Endocrinology; 1981 Jul; 109(1):62-9. PubMed ID: 7238414
[TBL] [Abstract][Full Text] [Related]
16. A DNA-binding (R-I) and a non-DNA-binding (R-II) estrogen receptor in the goat uterine nucleus: purification and characterization.
Karthikeyan N; Thampan RV
Arch Biochem Biophys; 1994 Mar; 309(2):205-13. PubMed ID: 8135529
[TBL] [Abstract][Full Text] [Related]
17. Cytosol type II sites in the rat uterus: interaction with an endogenous ligand.
Markaverich BM; Adams NR; Roberts RR; Alejandro M; Clark JH
J Steroid Biochem; 1987 Dec; 28(6):599-608. PubMed ID: 2826918
[TBL] [Abstract][Full Text] [Related]
18. Immunoelectron microscopic localization of estrogen receptor on pre-mRNA containing constituents of rat uterine cell nuclei.
Vázquez-Nin GH; Echeverría OM; Fakan S; Traish AM; Wotiz HH; Martin TE
Exp Cell Res; 1991 Feb; 192(2):396-404. PubMed ID: 1988286
[TBL] [Abstract][Full Text] [Related]
19. Identification of uterine nuclear type II estrogen binding sites in estrogen treated rats.
Sheehan DM; Medlock KL; Lyttle CR
J Steroid Biochem; 1986 Jul; 25(1):37-43. PubMed ID: 3747514
[TBL] [Abstract][Full Text] [Related]
20. Selective increase in type II estrogen-binding sites in the dysplastic dorsolateral prostates of noble rats.
Ho SM; Yu M
Cancer Res; 1993 Feb; 53(3):528-32. PubMed ID: 7678774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
